CXCL9 and autoimmune disease: INF‐γ is the only known stimulus of CXCL9 (Giamarellos‐Bourboulis et al. 2024), a chemokine that has been reported to rise in women with autoimmune diseases who develop CAD (Shamsi et al. 2023).